Cargando…

橙皮素通过激活SIRT1/NRF2信号改善阿霉素诱导的H9c2细胞毒性

OBJECTIVE: To investigate whether hesperetin (Hes) alleviates doxorubicin (DOX)-induced cardiomyocytotoxicity by reducing oxidative stress via regulating silent information regulator 1 (SIRT1)/nuclear transcription factor E2-related factor 2 (NRF2) signaling in H9c2 cells. METHODS: H9c2 cells were t...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 四川大学学报(医学版)编辑部 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579077/
https://www.ncbi.nlm.nih.gov/pubmed/37866951
http://dx.doi.org/10.12182/20230960207
_version_ 1785121644546621440
collection PubMed
description OBJECTIVE: To investigate whether hesperetin (Hes) alleviates doxorubicin (DOX)-induced cardiomyocytotoxicity by reducing oxidative stress via regulating silent information regulator 1 (SIRT1)/nuclear transcription factor E2-related factor 2 (NRF2) signaling in H9c2 cells. METHODS: H9c2 cells were treated with DOX to establish the cardiotoxicity model and were randomly assigned to four groups, a control group (Control) and three treatment groups, receiving respectively DOX (the DOX group), Hes+DOX (the DOX+Hes group), and Hes+SIRT1 inhibitor EX527+DOX (the DOX+Hes+EX527 group). Cellular morphology was observed by the light microscope. Cell viability was evaluated by CCK-8. DOX-induced apoptosis in H9c2 cells was examined by flow cytometry. The levels of reactive oxygen species (ROS) in the H9c2 cells of the four groups were determied with 2'-7'-dichlorodihydrofluorescein diacetate (DCFH-DA) staining. The activities of lactate dehydrogenase (LDH), superoxide dismutase (SOD), catalase (CAT), and SIRT1 as well as the malondialdehyde (MDA) content were measured using ELISA kits. The expressions of cleaved caspase-3, cytochrome c, SIRT1, Ac-FOXO1, NRF2, and heme oxygenase 1 (HO-1) were determined by Western blot. RESULTS: Compared with the Control group, the DOX group showed swollen cellular morphology, decreased cell density and viability, and increased LDH activity in the medium (P<0.01); both apoptosis and the expression of cleaved caspase-3 and cytochrome c increased (P<0.01); the activities of CAT and SOD decreased while the contents of MDA and ROS increased (P<0.01); the expression of SIRT1, NRF2, and HO-1 decreased, the activity of SIRT1 decreased, and the expression of Ac-FOXO1 increased (P<0.01). Compared with the DOX group, the DOX+Hes group showed improved cellular morphology, increased cell density and viability, and decreased LDH activity in the medium (P<0.01); the apoptosis and the expression of cleaved caspase-3 and cytochrome c decreased (P<0.01); the activities of CAT and SOD increased while the levels of MDA and ROS decreased (P<0.01); the expression of SIRT1, NRF2, and HO-1 increased, the activity of SIRT1 increased, and the expression of Ac-FOXO1 decreased (P<0.01). Comparison of the findings for the DOX+Hes group and the DOX+Hes+EX527 group showed that EX527 could block the protective effects of Hes against DOX-induced cell injury, oxidative stress, and SIRT1/NRF2 signaling. CONCLUSION: Hes inhibits oxidative stress and apoptosis via regulating SIRT1/NRF2 signaling, thereby reducing DOX-induced cardiotoxicity in H9c2 cells.
format Online
Article
Text
id pubmed-10579077
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher 四川大学学报(医学版)编辑部
record_format MEDLINE/PubMed
spelling pubmed-105790772023-10-18 橙皮素通过激活SIRT1/NRF2信号改善阿霉素诱导的H9c2细胞毒性 Sichuan Da Xue Xue Bao Yi Xue Ban 论 著 OBJECTIVE: To investigate whether hesperetin (Hes) alleviates doxorubicin (DOX)-induced cardiomyocytotoxicity by reducing oxidative stress via regulating silent information regulator 1 (SIRT1)/nuclear transcription factor E2-related factor 2 (NRF2) signaling in H9c2 cells. METHODS: H9c2 cells were treated with DOX to establish the cardiotoxicity model and were randomly assigned to four groups, a control group (Control) and three treatment groups, receiving respectively DOX (the DOX group), Hes+DOX (the DOX+Hes group), and Hes+SIRT1 inhibitor EX527+DOX (the DOX+Hes+EX527 group). Cellular morphology was observed by the light microscope. Cell viability was evaluated by CCK-8. DOX-induced apoptosis in H9c2 cells was examined by flow cytometry. The levels of reactive oxygen species (ROS) in the H9c2 cells of the four groups were determied with 2'-7'-dichlorodihydrofluorescein diacetate (DCFH-DA) staining. The activities of lactate dehydrogenase (LDH), superoxide dismutase (SOD), catalase (CAT), and SIRT1 as well as the malondialdehyde (MDA) content were measured using ELISA kits. The expressions of cleaved caspase-3, cytochrome c, SIRT1, Ac-FOXO1, NRF2, and heme oxygenase 1 (HO-1) were determined by Western blot. RESULTS: Compared with the Control group, the DOX group showed swollen cellular morphology, decreased cell density and viability, and increased LDH activity in the medium (P<0.01); both apoptosis and the expression of cleaved caspase-3 and cytochrome c increased (P<0.01); the activities of CAT and SOD decreased while the contents of MDA and ROS increased (P<0.01); the expression of SIRT1, NRF2, and HO-1 decreased, the activity of SIRT1 decreased, and the expression of Ac-FOXO1 increased (P<0.01). Compared with the DOX group, the DOX+Hes group showed improved cellular morphology, increased cell density and viability, and decreased LDH activity in the medium (P<0.01); the apoptosis and the expression of cleaved caspase-3 and cytochrome c decreased (P<0.01); the activities of CAT and SOD increased while the levels of MDA and ROS decreased (P<0.01); the expression of SIRT1, NRF2, and HO-1 increased, the activity of SIRT1 increased, and the expression of Ac-FOXO1 decreased (P<0.01). Comparison of the findings for the DOX+Hes group and the DOX+Hes+EX527 group showed that EX527 could block the protective effects of Hes against DOX-induced cell injury, oxidative stress, and SIRT1/NRF2 signaling. CONCLUSION: Hes inhibits oxidative stress and apoptosis via regulating SIRT1/NRF2 signaling, thereby reducing DOX-induced cardiotoxicity in H9c2 cells. 四川大学学报(医学版)编辑部 2023-09-20 /pmc/articles/PMC10579077/ /pubmed/37866951 http://dx.doi.org/10.12182/20230960207 Text en © 2023《四川大学学报(医学版)》编辑部 版权所有 https://creativecommons.org/licenses/by-nc/4.0/开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议访问 https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0). In other words, the full-text content of the journal is made freely available for third-party users to copy and redistribute in any medium or format, and to remix, transform, and build upon the content of the journal. You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may not use the content of the journal for commercial purposes. For more information about the license, visit https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 论 著
橙皮素通过激活SIRT1/NRF2信号改善阿霉素诱导的H9c2细胞毒性
title 橙皮素通过激活SIRT1/NRF2信号改善阿霉素诱导的H9c2细胞毒性
title_full 橙皮素通过激活SIRT1/NRF2信号改善阿霉素诱导的H9c2细胞毒性
title_fullStr 橙皮素通过激活SIRT1/NRF2信号改善阿霉素诱导的H9c2细胞毒性
title_full_unstemmed 橙皮素通过激活SIRT1/NRF2信号改善阿霉素诱导的H9c2细胞毒性
title_short 橙皮素通过激活SIRT1/NRF2信号改善阿霉素诱导的H9c2细胞毒性
title_sort 橙皮素通过激活sirt1/nrf2信号改善阿霉素诱导的h9c2细胞毒性
topic 论 著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579077/
https://www.ncbi.nlm.nih.gov/pubmed/37866951
http://dx.doi.org/10.12182/20230960207
work_keys_str_mv AT chéngpísùtōngguòjīhuósirt1nrf2xìnhàogǎishànāméisùyòudǎodeh9c2xìbāodúxìng
AT chéngpísùtōngguòjīhuósirt1nrf2xìnhàogǎishànāméisùyòudǎodeh9c2xìbāodúxìng
AT chéngpísùtōngguòjīhuósirt1nrf2xìnhàogǎishànāméisùyòudǎodeh9c2xìbāodúxìng
AT chéngpísùtōngguòjīhuósirt1nrf2xìnhàogǎishànāméisùyòudǎodeh9c2xìbāodúxìng
AT chéngpísùtōngguòjīhuósirt1nrf2xìnhàogǎishànāméisùyòudǎodeh9c2xìbāodúxìng